Malley Thomas bought KNSA
August 12, 2025 · Form 4 insider transaction
Malley Thomas bought 21,959 shares of Kiniksa Pharmaceuticals International, plc at $1.86 per share, a transaction worth $40.8K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
21,959
Price
$1.86
Total value
$40.8K
InsiderMalley Thomas
RoleDirector
SecurityClass A Ordinary Shares
Transaction codeM: Option exercise
Transaction dateAugust 12, 2025
Filing dateAugust 14, 2025
Shares owned after34,505
OwnershipDirect
10b5-1 planNo
AmendedNo